Management of Depression and ADHD

Treatment Approach

• The American College of Physicians recommends continuing treatment for 4-9 months after achieving satisfactory response in a first episode of major depression, with longer duration for patients with recurrent episodes 3.
• The combination of bupropion and stimulant is appropriate for treating comorbid depression and ADHD, as stimulants remain first-line for ADHD with 70-80% response rates, and bupropion effectively addresses depressive symptoms 4.

Monitoring and Assessment

• Regular assessment at 4-week intervals is recommended for patients on pharmacologic treatment for depression and anxiety, and this patient is being seen appropriately for follow-up 1, 2.
• The patient should continue to be assessed using standardized validated instruments to monitor symptom relief, side effects, and satisfaction with treatment 1.

Addressing Concerns

• Reduced appetite is a common and expected side effect of both bupropion and lisdexamfetamine, but does not require medication adjustment when the patient is eating regularly and working with a nutritionist 5.
• Emergence of suicidal ideation, self-harm behaviors, or psychotic symptoms would require urgent reassessment and potential hospitalization 1, 3.

Continuation Plan

• Antidepressant treatment should continue for 4-9 months after achieving satisfactory response in a first episode of major depression, with longer duration for patients with recurrent episodes 3.
• The patient's use of sleep hygiene techniques and sleep tracking apps should be encouraged as non-pharmacologic approaches to maintaining sleep quality 1, 2.